Statement Of Financial Position [Abstract]

Xspray Pharma - Filing #679275

Concept	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31
Statement of financial position [abstract]
Assets [abstract]
Right-of-use assets	—	—	—	—	37 649 SEK	—	2 477 SEK	—	—	—	—	—	—	—	—	—	—	—
Cash and cash equivalents	—	—	—	—	166 303 SEK	—	120 166 SEK	—	—	—	—	—	271 881 SEK	—	—	—	—	—
Assets	—	—	—	—	765 263 SEK	—	585 430 SEK	—	—	—	—	—	—	—	—	—	—	—
Equity and liabilities [abstract]
Equity [abstract]
Issued capital	—	—	—	—	31 254 SEK	—	22 680 SEK	—	—	—	—	—	—	—	—	—	—	—
Retained earnings	—	—	—	—	554 724 SEK	—	375 057 SEK	—	—	—	—	—	—	—	—	—	—	—
Other reserves	—	—	—	—	792,000 SEK	—	976,000 SEK	—	—	—	—	—	—	—	—	—	—	—
Equity attributable to owners of parent	—	—	—	—	693 413 SEK	—	556 019 SEK	—	—	—	—	—	—	—	—	—	—	—
Equity	31 253 SEK	184,000 SEK	1 216 093 SEK	554 724 SEK	693 413 SEK	976,000 SEK	556 019 SEK	375 057 SEK	22 680 SEK	- SEK	976,000 SEK	907 420 SEK	591 752 SEK	243 387 SEK	976,000 SEK	813 483 SEK	- SEK	20 680 SEK
Equity and liabilities	—	—	—	—	765 263 SEK	—	585 430 SEK	—	—	—	—	—	—	—	—	—	—	—